Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?

The purpose of this study is to examine gender differences in quality of life (QoL) and symptomatology in fibromyalgia (FM) patients. A total of 20 men (48.0 ± 8.0 years) and 78 women (49.8 ± 7.2 years) with FM participated in the study (age range 31-63 years). Health-related QoL and FM impact were...

Full description

Bibliographic Details
Main Authors: Virginia A. Aparicio PhD, Francisco B. Ortega PhD, Ana Carbonell-Baeza PhD, Pedro Femia PhD, Pablo Tercedor PhD, Jonatan R. Ruiz PhD, Manuel Delgado-Fernández PhD
Format: Article
Language:English
Published: SAGE Publishing 2012-07-01
Series:American Journal of Men's Health
Online Access:https://doi.org/10.1177/1557988312436872
_version_ 1818043008980877312
author Virginia A. Aparicio PhD
Francisco B. Ortega PhD
Ana Carbonell-Baeza PhD
Pedro Femia PhD
Pablo Tercedor PhD
Jonatan R. Ruiz PhD
Manuel Delgado-Fernández PhD
author_facet Virginia A. Aparicio PhD
Francisco B. Ortega PhD
Ana Carbonell-Baeza PhD
Pedro Femia PhD
Pablo Tercedor PhD
Jonatan R. Ruiz PhD
Manuel Delgado-Fernández PhD
author_sort Virginia A. Aparicio PhD
collection DOAJ
description The purpose of this study is to examine gender differences in quality of life (QoL) and symptomatology in fibromyalgia (FM) patients. A total of 20 men (48.0 ± 8.0 years) and 78 women (49.8 ± 7.2 years) with FM participated in the study (age range 31-63 years). Health-related QoL and FM impact were assessed by means of the Spanish versions of the Short-Form-36 Health Survey (SF36) and the Fibromyalgia Impact Questionnaire (FIQ), respectively. Comparisons in QoL were performed using one-way analysis of covariance adjusted by age and body mass index (BMI), and comparisons in FIQ dimensions were performed using Mann-Whitney test. Overall FM impact, as measured by FIQ-total score ( p = .01) and FIQ-physical impairment ( p = .02) was higher in men, whereas women presented higher values of FIQ-fatigue and FIQ-morning tiredness ( p = .04) and less SF36-vitality ( p = .02). Therefore, women appear to feel more fatigue, whereas men present higher FM overall impact. Due to the small number of men included in this study and the consequent small statistical power, these results should be taken as preliminary. Higher powered studies are warranted to further address gender differences in FM in order to design more successful treatments.
first_indexed 2024-12-10T08:55:23Z
format Article
id doaj.art-cd33b0b5476648278baf986a10a4dc4c
institution Directory Open Access Journal
issn 1557-9883
1557-9891
language English
last_indexed 2024-12-10T08:55:23Z
publishDate 2012-07-01
publisher SAGE Publishing
record_format Article
series American Journal of Men's Health
spelling doaj.art-cd33b0b5476648278baf986a10a4dc4c2022-12-22T01:55:27ZengSAGE PublishingAmerican Journal of Men's Health1557-98831557-98912012-07-01610.1177/1557988312436872Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?Virginia A. Aparicio PhD0Francisco B. Ortega PhD1Ana Carbonell-Baeza PhD2Pedro Femia PhD3Pablo Tercedor PhD4Jonatan R. Ruiz PhD5Manuel Delgado-Fernández PhD6Karolinska Institute, Stockholm, SwedenKarolinska Institute, Stockholm, SwedenUniversity of Cádiz, Cádiz, SpainUniversity of Granada, Granada, SpainUniversity of Granada, Granada, SpainKarolinska Institute, Stockholm, SwedenUniversity of Granada, Granada, SpainThe purpose of this study is to examine gender differences in quality of life (QoL) and symptomatology in fibromyalgia (FM) patients. A total of 20 men (48.0 ± 8.0 years) and 78 women (49.8 ± 7.2 years) with FM participated in the study (age range 31-63 years). Health-related QoL and FM impact were assessed by means of the Spanish versions of the Short-Form-36 Health Survey (SF36) and the Fibromyalgia Impact Questionnaire (FIQ), respectively. Comparisons in QoL were performed using one-way analysis of covariance adjusted by age and body mass index (BMI), and comparisons in FIQ dimensions were performed using Mann-Whitney test. Overall FM impact, as measured by FIQ-total score ( p = .01) and FIQ-physical impairment ( p = .02) was higher in men, whereas women presented higher values of FIQ-fatigue and FIQ-morning tiredness ( p = .04) and less SF36-vitality ( p = .02). Therefore, women appear to feel more fatigue, whereas men present higher FM overall impact. Due to the small number of men included in this study and the consequent small statistical power, these results should be taken as preliminary. Higher powered studies are warranted to further address gender differences in FM in order to design more successful treatments.https://doi.org/10.1177/1557988312436872
spellingShingle Virginia A. Aparicio PhD
Francisco B. Ortega PhD
Ana Carbonell-Baeza PhD
Pedro Femia PhD
Pablo Tercedor PhD
Jonatan R. Ruiz PhD
Manuel Delgado-Fernández PhD
Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?
American Journal of Men's Health
title Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?
title_full Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?
title_fullStr Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?
title_full_unstemmed Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?
title_short Are There Gender Differences in Quality of Life and Symptomatology Between Fibromyalgia Patients?
title_sort are there gender differences in quality of life and symptomatology between fibromyalgia patients
url https://doi.org/10.1177/1557988312436872
work_keys_str_mv AT virginiaaapariciophd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients
AT franciscobortegaphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients
AT anacarbonellbaezaphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients
AT pedrofemiaphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients
AT pablotercedorphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients
AT jonatanrruizphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients
AT manueldelgadofernandezphd aretheregenderdifferencesinqualityoflifeandsymptomatologybetweenfibromyalgiapatients